Day Three – 18 June 2025 - CEST Time Zone
- Gert Bos - Executive Director & Partner, Qserve Group
- Cécile van der Heijden - Senior Attorney-at-Law, Axon Lawyers
- Abhineet Johri - Regulatory Affairs Manager & Senior Key Expert-AI, Siemens Healthineers
- Leon Doorn - QAIR.io, Independent Regulatory Affairs Consultant
With so much buzz around the EU AI Act, what actually is it and why is it so important for industry?
- Does it only affect manufacturers with AI-enabled devices?
- Is it already implemented and are there transition times?
- What implications are there for industry, notified bodies and regulators?
- Where does the AI Act sit within our regulations
- Link to EU MDR / IVDR, GDPR, Cybersecurity, etc...
- What are the ethical considerations in regard to the AI Act
- Importance of considering ethics for regulatory affairs teams
- Use cases
- Which special considerations are there for designing quality systems in line with the AI Act?
- Can manufacturers utilise their pre-existing system, or is a new one needed
Does the AI Act describe data requirements?
Which evidence is required for certification under the Act?
How does this interact with data requirements from other regulations?
Does it differ based on device risk class?
How do you know if it is sufficient?
How do you ensure the data is GDPR compliance?
- Leon Doorn - QAIR.io, Independent Regulatory Affairs Consultant
- Cécile van der Heijden - Senior Attorney-at-Law, Axon Lawyers
- Abhineet Johri - Regulatory Affairs Manager & Senior Key Expert-AI, Siemens Healthineers
- Gert Bos - Executive Director & Partner, Qserve Group
- Cécile van der Heijden - Senior Attorney-at-Law, Axon Lawyers
- Abhineet Johri - Regulatory Affairs Manager & Senior Key Expert-AI, Siemens Healthineers
- Leon Doorn - QAIR.io, Independent Regulatory Affairs Consultant
- Once desirable data has been identified, how do you collect this data and use it to support claims?
- Which types of studies are most effective for collecting data in regard to the EU AI Act?
How does the EU AI Act interact with post-market surveillance and vigilance requirements?
Are there additional requirements which need to be considered?
How do you monitor post-market for non-static devices and diagnostics?
- Gert Bos - Executive Director & Partner, Qserve Group
- Leon Doorn - QAIR.io, Independent Regulatory Affairs Consultant
Take this time to put together a mock submission for a device in line with the Act
Compare and contrast with other workshop participants and gain invaluable feedback from trainers
Open Q&A
- Leon Doorn - QAIR.io, Independent Regulatory Affairs Consultant
- Gert Bos - Executive Director & Partner, Qserve Group
- Cécile van der Heijden - Senior Attorney-at-Law, Axon Lawyers
- Abhineet Johri - Regulatory Affairs Manager & Senior Key Expert-AI, Siemens Healthineers